Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3919889 | 0.78 | GPR3 (0.46) | POLBMEN1KMT2AATMGPR3 | |
| SCHEMBL4634572 | 0.76 | GPR3 (0.38) | POLBMEN1KMT2AATMGPR3 | |
| SCHEMBL3701444 | 0.75 | HTR2A (0.40) | POLBGPR3CYP1A2HTR2A | |
| SCHEMBL8744967 | 0.73 | GPR3 (0.34) | GPR3CYP1A2HTR2A | |
| SCHEMBL7840975 | 0.72 | KMT2A (0.35) | POLBMEN1KMT2AGPR3HTR2A | |
| SCHEMBL6424856 | 0.72 | HTR2A (0.38) | GPR3HTR2A | |
| SCHEMBL9422237 | 0.71 | GPR3 (0.34) | POLBGPR3HTR2A | |
| SCHEMBL6306483 | 0.71 | HTR2A (0.42) | GPR3HTR2A | |
| SCHEMBL8086417 | 0.71 | GPR3 (0.34) | POLBGPR3HTR2A | |
| SCHEMBL8155267 | 0.71 | GPR3 (0.34) | POLBGPR3HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0627440-B1 | Metallocenes containing 9-substituted fluorenyl compounds and use of the metallocenes | PHILLIPS PETROLEUM CO (US) | 1999-08-18 | — | — | EP | claimed |
| US-5610247-A | Unbridged metallocenes of 9-substituted fluorenyl compounds and use thereof | PHILLIPS PETROLEUM COMPANY (US) | 1997-03-11 | — | — | US | claimed |
| EP-0627440-A1 | 9-Substituted fluorenyl compounds and the preparation and use of metallocenes thereof | PHILLIPS PETROLEUM COMPANY (US) | 1994-12-07 | — | — | EP | claimed |
| US-6849753-B2 | Process for preparation of half-vanadocene compound | NICHIA CORPORATION (JP) | 2005-02-01 | — | — | US | disclosed |
| EP-1312610-B1 | Process for preparation of half-vanadocene compound | NICHIA CORP (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-20030109733-A1 | Process for preparation of half-vanadocene compound | UBE INDUSTRIES, LTD. (JP) | 2003-06-12 | — | — | US | disclosed |
| CN-1420118-A | Method for preparing semi-cyclopentadienyl vanadium | NICHIA KAGAKU KOGYO KK (JP) | 2003-05-28 | — | — | CN | disclosed |
| EP-1312610-A1 | Process for preparation of half-vanadocene compound | Nichia Corporation (JP) | 2003-05-21 | — | — | EP | disclosed |
| EP-0627440-B1 | Metallocenes containing 9-substituted fluorenyl compounds and use of the metallocenes | PHILLIPS PETROLEUM CO (US) | 1999-08-18 | — | — | EP | disclosed |
| US-5610247-A | Unbridged metallocenes of 9-substituted fluorenyl compounds and use thereof | PHILLIPS PETROLEUM COMPANY (US) | 1997-03-11 | — | — | US | disclosed |
| EP-0627440-A1 | 9-Substituted fluorenyl compounds and the preparation and use of metallocenes thereof | PHILLIPS PETROLEUM COMPANY (US) | 1994-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030109733-A1 | Process for preparation of half-vanadocene compound | CPNE4, VDAC2, VDAC1 | POLB 1416/4885MEN1 2168/4885KMT2A 1599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.